1.Amlodipine monotherapy in patients with essential hypertension.
Kyung Soo KIM ; Jung Hyun KIM ; Hun Kil LIM ; Bang Hun LEE ; Jung Kyoon LEE
The Korean Journal of Critical Care Medicine 1993;8(1):59-63
No abstract available.
Amlodipine*
;
Humans
;
Hypertension*
2.Clinical effects of doxazosin in the treatment of essential hypertension.
Kyung Soo KIM ; Jung Hyun KIM ; Hun Kil LIM ; Bang Hun LEE ; Jung Kyoon LEE
The Korean Journal of Critical Care Medicine 1993;8(1):21-26
No abstract available.
Doxazosin*
;
Hypertension*
3.Effects of lovastatin on serum lipids of patients with primary hypercholesterolemia.
Kyung Soo KIM ; Jung Hyun KIM ; Hun Kil LIM ; Bang Hun LEE ; Jung Kyoon LEE
The Korean Journal of Critical Care Medicine 1993;8(1):7-11
No abstract available.
Humans
;
Hypercholesterolemia*
;
Lovastatin*
5.The Lumbar Discogram Incidental to the Operation: Analysis of 35 Cases
Byung Kook KIM ; Young Joe KIM ; Hun Soo JUNG
The Journal of the Korean Orthopaedic Association 1976;11(1):11-18
Since the time when the lumbar discogram was used as the clinical diagnostic method for the first time in 1952, many problems have been pointed out to this method, and moreover, in presentday tendencies for the diagnostic method, the lumbar discogram is carried on even useless by majority. One of the important reasons is that so many studies for the lumbar discograms have reported so many false positive lumbar discograms at the high ratio. Hower we found a certain usefulness of the lumbar discogram incidental to the operation. The purposes of our operative lumbar discogram are those; 1) to observe the radiological configuration of the lumbar discogram. 2) to measure the amount of the the dye injected into normal and abnormal lumbar discs, especially in our Koreans. 3) for confirmation of the diagnosis when the myelographic finding is suspicious. 4) for confirmation of the Ievel especially when the number of the possible lesion is more than one. We investigated and analyzed the 35 lumbar discograms of 26 patients and compiled the statistics.
Diagnosis
;
Humans
;
Methods
6.Kaposi's Sarcoma with Skeletal Lesion: A case report
Young Joe KIM ; Hun Soo JUNG ; Keun Yull MAING
The Journal of the Korean Orthopaedic Association 1977;12(1):75-80
The morphologic unit of the disease process currently referred to as Kaposi's sarcoma consists of a complex growth of vascular channels and mesenchymal cells of various types and in different phases of differentiation. Kaposi's sarcoma, with its characteristic skin lesion, is an entity familiar to the pathologist and dermatologist. This case report represents an unusal bone cortex involvement of Kaposi's sarcoma with skin lesion in a lower extremity, which has survived for 26 years without no specific abnormality in laboratory study and no specific clinical change.
Lower Extremity
;
Sarcoma, Kaposi
;
Skin
7.The Cloward Operation of the Cervical and Lumbar Spine
Young Joe KIM ; Hun Soo JUNG ; Keun Yull MAING
The Journal of the Korean Orthopaedic Association 1978;13(1):29-34
Anterior cervical interbody fusion and posterior lumbar interbody fusion of the Clowards technique is based on those; 1. removal of the painful disc. 2. stabilization of the unstable joint by interbody fusion. This technique has many advantages compared with the others including followings; 1. very simple technique. 2. low morbidity. 3. rapid recovery. 4. no need of the external support device postoperatively. We operated 5 cervical spines and 2 lumbar ones. This is the report of their follow up study in 2 to 2 years.
Follow-Up Studies
;
Joints
;
Spine
8.Vitilligo Induced by Diphencyprone in a Patient with Alopecia Areata.
Soo Jung KIM ; Won Soo LEE ; Seung Hun LEE ; Sung Ku AHN
Korean Journal of Dermatology 1994;32(5):934-938
Common adverse effects due to topical therapy with DPCP(Diphenyprone) are severe contact dermatitis, dermographism, urticaria, generalized pruritus, lymphadenoiathy, and dermatitis on the remote areas. Rarely, DPCP can induce vitiligo or dyschromia in confetias side effects on the pigmentary system. It is not clear yet whither DPCP induced the vitiligcbatoxic effect of phenol ring in DPCP or by koebner phenomenon clue to repeated contact dermatitis in cases where vitiligo was in latent subclinical condition. We describe a patient with alopecia areatairho developed vitiligo due to topical therapy with DPCP. A 20-year-old woman developed alopecia areata with a loss of eye shows and eyelashes. After sensitization, DPCP was topically applieid to the scalp every week. Vitiligo, confirmed by electron microscopic study, appeared 4 month. after the beginning of treatment and was localized only to the areas of topical application. Both alogecia aieata and vitiligo are improving now under systemic and topical corticosteroid therapy.
Alopecia Areata*
;
Alopecia*
;
Dermatitis
;
Dermatitis, Contact
;
Eyelashes
;
Female
;
Humans
;
Phenol
;
Pruritus
;
Scalp
;
Urticaria
;
Vitiligo
;
Young Adult
9.Experimental Study of Calcinosis Cutis after Extravasation of Calcium Gluconate.
Kyun Tae KIM ; Soo Jung KIM ; Seung Hun LEE ; Sung Ku AHN ; Won Soo LEE
Korean Journal of Dermatology 1994;32(4):574-582
BACKGROUND: Neonatal hypocalcemia is not an infrequent condition, especially in the premature neonate. It is effectively treated by intravenous administration of calcium gluconate. Complications of extravasation during intraveous infusion included calcification and, occasionally necrosis. But the exact mechanism of calcinosis cutis following extravasation of calcium gluconate remains unknown and there is no specific mode of treatment except cold packs and skin graft. OBJECTIVE: Our purpose was to evaluate the clinical and histological features in rabbits after subcutaneous injection of 10% calcium gluconate and a mixed solution of gluconate and triamcinolone acetonide. METHODS: Two rabbits were divided into 3 groups and were subcutaneously injected with the following materials on the back; 10% calcium gluconate, a mixed solution of calcium gluconate and triamcinolone acetonide, and 25% normal saline as controls respectively. The injection site including the skin and subcutaneous fat was excised and fixed with natural buffered formalin. The biopsied specimens were stained with Hematolxylin and Eosin. RESULTS: 1) In the 10% calcium gluconate injected group, there was some erthema and induration after three days. By the fifth to the seventh days there was more erythema and firm induration. At 15 days, nodules and large ulcreated lesions developed. Multiple, linear shaped, ulcreative surfaced and indurated masses were noted at 37days.l from 45days to 2months there was progressive healing with decrease in ulceration, and gradual disapppearance of the mass. Histologically, at the 8th day calcium was seen in the walls of the arteries and veins, after 15days, the reaction was at its peak and epidermal necrosis was seen on the injected site. From 30 to 3days, calcium deposition and granuloma formation were seen in the dermis. In addition discharge of calcium deposits began to place by means of transepidermal elimination. After 45days, although the response was subsiding, the calcium and mucin deposition was observed focally in the dermis. 2. In the 10% calcium gluconate and triamcinolone acetonide adjuvant injected group, there was development of some erythema at 8days. After 15days, some erythema and induration were seen of the injected site ad this gradually disappeared. By 37days, the injection site was normal in appearance. Histologically, at 15days calcium deposition was seen on the upper dermis and the injection site was histologically normal after one month. 3. In 25% normal saline injected group, the injection site was clinically normal. Histologically there was no reaction except for focal perivascular eosinophilia after 24horus. CONCLUSION: We conclude that the important mechanism of calcinosis cutis appears to be elevated concentration as well as the tissue damage at the site of the extravasation of calcium gluconate. The final common pathway of calcification is the formation of crystalline and insoluble calcium phosphate mineral, in the form of hydroxyapatite. The intralesional injection of triamcinolone for the treatment of calcinosis cutis in our study was effective due to its antiinflammatory effect and the reabsorption of calcium in the tissues.
Administration, Intravenous
;
Arteries
;
Bowen's Disease
;
Calcinosis*
;
Calcium Gluconate*
;
Calcium*
;
Carcinoma, Squamous Cell
;
Crystallins
;
Dermis
;
Durapatite
;
Eosine Yellowish-(YS)
;
Eosinophilia
;
Erythema
;
Formaldehyde
;
Granuloma
;
Humans
;
Hypocalcemia
;
Infant, Newborn
;
Injections, Intralesional
;
Injections, Subcutaneous
;
Keratoacanthoma
;
Keratosis, Actinic
;
Mucins
;
Necrosis
;
Proliferating Cell Nuclear Antigen
;
Rabbits
;
Skin
;
Subcutaneous Fat
;
Transplants
;
Triamcinolone
;
Triamcinolone Acetonide
;
Ulcer
;
Veins
10.Experimental Study of Calcinosis Cutis after Extravasation of Calcium Gluconate.
Kyun Tae KIM ; Soo Jung KIM ; Seung Hun LEE ; Sung Ku AHN ; Won Soo LEE
Korean Journal of Dermatology 1994;32(4):574-582
BACKGROUND: Neonatal hypocalcemia is not an infrequent condition, especially in the premature neonate. It is effectively treated by intravenous administration of calcium gluconate. Complications of extravasation during intraveous infusion included calcification and, occasionally necrosis. But the exact mechanism of calcinosis cutis following extravasation of calcium gluconate remains unknown and there is no specific mode of treatment except cold packs and skin graft. OBJECTIVE: Our purpose was to evaluate the clinical and histological features in rabbits after subcutaneous injection of 10% calcium gluconate and a mixed solution of gluconate and triamcinolone acetonide. METHODS: Two rabbits were divided into 3 groups and were subcutaneously injected with the following materials on the back; 10% calcium gluconate, a mixed solution of calcium gluconate and triamcinolone acetonide, and 25% normal saline as controls respectively. The injection site including the skin and subcutaneous fat was excised and fixed with natural buffered formalin. The biopsied specimens were stained with Hematolxylin and Eosin. RESULTS: 1) In the 10% calcium gluconate injected group, there was some erthema and induration after three days. By the fifth to the seventh days there was more erythema and firm induration. At 15 days, nodules and large ulcreated lesions developed. Multiple, linear shaped, ulcreative surfaced and indurated masses were noted at 37days.l from 45days to 2months there was progressive healing with decrease in ulceration, and gradual disapppearance of the mass. Histologically, at the 8th day calcium was seen in the walls of the arteries and veins, after 15days, the reaction was at its peak and epidermal necrosis was seen on the injected site. From 30 to 3days, calcium deposition and granuloma formation were seen in the dermis. In addition discharge of calcium deposits began to place by means of transepidermal elimination. After 45days, although the response was subsiding, the calcium and mucin deposition was observed focally in the dermis. 2. In the 10% calcium gluconate and triamcinolone acetonide adjuvant injected group, there was development of some erythema at 8days. After 15days, some erythema and induration were seen of the injected site ad this gradually disappeared. By 37days, the injection site was normal in appearance. Histologically, at 15days calcium deposition was seen on the upper dermis and the injection site was histologically normal after one month. 3. In 25% normal saline injected group, the injection site was clinically normal. Histologically there was no reaction except for focal perivascular eosinophilia after 24horus. CONCLUSION: We conclude that the important mechanism of calcinosis cutis appears to be elevated concentration as well as the tissue damage at the site of the extravasation of calcium gluconate. The final common pathway of calcification is the formation of crystalline and insoluble calcium phosphate mineral, in the form of hydroxyapatite. The intralesional injection of triamcinolone for the treatment of calcinosis cutis in our study was effective due to its antiinflammatory effect and the reabsorption of calcium in the tissues.
Administration, Intravenous
;
Arteries
;
Bowen's Disease
;
Calcinosis*
;
Calcium Gluconate*
;
Calcium*
;
Carcinoma, Squamous Cell
;
Crystallins
;
Dermis
;
Durapatite
;
Eosine Yellowish-(YS)
;
Eosinophilia
;
Erythema
;
Formaldehyde
;
Granuloma
;
Humans
;
Hypocalcemia
;
Infant, Newborn
;
Injections, Intralesional
;
Injections, Subcutaneous
;
Keratoacanthoma
;
Keratosis, Actinic
;
Mucins
;
Necrosis
;
Proliferating Cell Nuclear Antigen
;
Rabbits
;
Skin
;
Subcutaneous Fat
;
Transplants
;
Triamcinolone
;
Triamcinolone Acetonide
;
Ulcer
;
Veins